214 related articles for article (PubMed ID: 14656925)
1. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway.
Hao L; Du M; Lopez-Campistrous A; Fernandez-Patron C
Circ Res; 2004 Jan; 94(1):68-76. PubMed ID: 14656925
[TBL] [Abstract][Full Text] [Related]
2. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
Nagareddy PR; MacLeod KM; McNeill JH
Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
[TBL] [Abstract][Full Text] [Related]
3. Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species.
Hao L; Nishimura T; Wo H; Fernandez-Patron C
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):819-25. PubMed ID: 16424353
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy.
Shah BH; Catt KJ
Trends Endocrinol Metab; 2004 Aug; 15(6):241-3. PubMed ID: 15358274
[TBL] [Abstract][Full Text] [Related]
6. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries.
Lucchesi PA; Sabri A; Belmadani S; Matrougui K
Circulation; 2004 Dec; 110(23):3587-93. PubMed ID: 15557365
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
Cheng K; Xie G; Raufman JP
Biochem Pharmacol; 2007 Apr; 73(7):1001-12. PubMed ID: 17222808
[TBL] [Abstract][Full Text] [Related]
8. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
11. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
12. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
13. Heparin binding EGF is necessary for vasospastic response to endothelin.
Chansel D; Ciroldi M; Vandermeersch S; Jackson LF; Gomez AM; Henrion D; Lee DC; Coffman TM; Richard S; Dussaule JC; Tharaux PL
FASEB J; 2006 Sep; 20(11):1936-8. PubMed ID: 16877529
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis.
Nagareddy PR; Chow FL; Hao L; Wang X; Nishimura T; MacLeod KM; McNeill JH; Fernandez-Patron C
Cardiovasc Res; 2009 Dec; 84(3):368-77. PubMed ID: 19578070
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
[TBL] [Abstract][Full Text] [Related]
16. Role of metalloproteinase-dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons.
Shah BH; Shah FB; Catt KJ
J Neurochem; 2006 Jan; 96(2):520-32. PubMed ID: 16336626
[TBL] [Abstract][Full Text] [Related]
17. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
Roztocil E; Nicholl SM; Galaria II; Davies MG
Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
[TBL] [Abstract][Full Text] [Related]
18. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Xu KP; Ding Y; Ling J; Dong Z; Yu FS
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors.
Zhang D; Zhang J; Jiang X; Li X; Wang Y; Ma J; Jiang H
J Gastroenterol Hepatol; 2014 Mar; 29(3):623-32. PubMed ID: 24303948
[TBL] [Abstract][Full Text] [Related]
20. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
